KIM-1 and NGAL Biomarkers for Kidney Disease Investigation
Okay, here’s a breakdown of the bibliographic information from the provided text, formatted for clarity. I’ve included as much detail as possible, noting any inconsistencies or potential errors.
reference List
- Al-Aly Z, Xie Y, Bowe B, et al. Long-term cardiovascular consequences of COVID-19. Nat Med. 2022; 28(6): 1119-1128. Doi: 10.1038/s41591-022-01972-x
- Al-Aly Z, Xie Y, Bowe B, et al. Post-COVID conditions and risk of incident cardiovascular disease. Circulation. 2023; 147(16): 1343-1354. Doi: 10.1161/CIRCULATIONAHA.122.061587
- Al-Aly Z,Xie Y,Bowe B,et al. Persistent cardiac dysfunction after COVID-19. JAMA. 2023; 329(11): 930-932. Doi: 10.1001/jama.2023.3223
- Tsao CW, Aday AW, Adler JA, et al. Heart disease and stroke statistics-2023 update: a report from the American heart Association. Circulation. 2023; 147(11): e672-e695. Doi: 10.1161/CIRCULATIONAHA.122.061406
- Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019; 139(10): e564-e601. Doi: 10.1161/CIRCULATIONAHA.118.037589
- Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the american Heart Association. Circulation. 2020; 141(9): e139-e169. Doi: 10.1161/CIRCULATIONAHA.119.042437
- Virani SS,Alonso A,Aparicio HJ,et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021; 143(18): e1257-e1379. Doi: 10.1161/CIRCULATIONAHA.120.050858
- Sørensen HT, Hansen PR, Hørby Jensen L, et al. Long-term cardiovascular risk after incident acute kidney injury. J Am Soc Nephrol. 2019; 30(6): 944-955.Doi: 10.1681/ASN.2018121300
- Singer E, Markó L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol. 2013; 207 (4): 663-672. Doi: 10.1111/apha.12054
- Gardiner L, Akintola A, Chen G, et al. Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease. Am J Nephrol. 2012;35:152-163. doi:10.1159/000335579
- Carter JL, parker CT, Stevens PE, et al. Biological variation of plasma and urinary markers of acute kidney injury in patients with CKD. Clin Chem.2016; 62 (6): 876-883. Doi: 10.13
